Encysive Pharmaceuticals has announced the launch of sitaxentan [Thelin] in France for the treatment of pulmonary arterial hypertension

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1610, 2007-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitaxentan: In Pulmonary Arterial Hypertension

By Scott Lesley J.  

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 761-770

Adis International

Access to resources Recommend Favorite

Sitaxentan [Thelin; Encysive Pharmaceuticals] 100mg tablets have been launched in Belgium and Luxembourg

By  

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Sitaxentan in Pulmonary Arterial Hypertension: A Viewpoint by Steven Kawut

By Kawut Steven  

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 771-772

Adis International

Access to resources Recommend Favorite

Sitaxentan: a guide to its use in pulmonary arterial hypertension

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 9, 2007-09 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Pharmacologic Treatment of Pulmonary Arterial Hypertension

By  

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 3963-3973

Bentham Science Publishers

Access to resources Recommend Favorite